A trial of RIT-4237 rotavirus vaccine in 1-month-old infants
- PMID: 2545451
- DOI: 10.1007/BF00441518
A trial of RIT-4237 rotavirus vaccine in 1-month-old infants
Abstract
In a double blind placebo-controlled study rotavirus vaccine RIT 4237 was offered to young infants after the fourth week of life. The vaccine was very well tolerated. Fifty-seven out of 100 vaccine recipients and 10 out of 103 placebo recipients developed rotavirus-IgM-antibodies during the 1 month follow-up period. During a 6 month follow-up, stool samples from 2 out of 12 vaccinees and from 5 out of 12 placebo recipients contained rotavirus.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical